Option Care Health, Inc.
A provider of home infusion therapy, delivering intravenous and injectable treatments for infections, immune disorders, and chronic illnesses directly to patients' homes. It began in 1979 when two California pharmacists, moved by a young car-accident patient who needed daily IV nutrition, pioneered bringing hospital-style infusion care into the home. The name "Option Care" was originally an acronym for "Outpatient Parenteral Therapy Intravenous Ongoing Nutrition with Care," and today's company formed in 2019 when Option Care Enterprises merged with BioScrip.
Sold 97.70M
Sold 26.48M
Sold 10.86M
Granted 1.72M · Bought 4.20M · Sold 2.85M
Bought 1.19M
Granted 1.54M · Sold 1.77M
Granted 1.08M · Bought 22.5K
Granted 203.4K · Bought 333.6K
Granted 496.7K · Bought 31.0K
Granted 408.5K · Bought 2.5K · Sold 23.2K
Bought 117.5K · Sold 532.6K
Granted 533.1K · Bought 20.0K · Sold 270.0K
Granted 120.4K · Bought 80.0K · Sold 27.0K
Granted 194.8K
Granted 97.1K · Bought 101.0K · Sold 11.2K
Granted 178.1K · Bought 10.0K
Granted 133.9K · Bought 25.0K
Granted 120.0K · Bought 15.0K
Granted 250.5K · Bought 43.5K
Granted 63.5K · Bought 50.0K
Granted 197.4K
Granted 82.1K · Bought 16.2K
Granted 89.7K
Granted 139.6K · Bought 44.2K · Sold 97.75M
Granted 83.6K
Granted 386.8K · Sold 48.0K
Granted 100.0K
Granted 108.8K · Bought 2.5K
Granted 117.5K
Granted 85.9K · Bought 3.0K · Sold 22.4K
Granted 63.5K · Bought 300
Granted 107.8K
Sold 41.3K
Granted 50.0K
Granted 50.0K
Granted 50.0K
Granted 38.0K
Granted 135.1K · Sold 28.0K
Granted 146.1K · Sold 96.1K
Granted 20.5K · Bought 30.0K · Sold 10.5K
Granted 33.5K
Granted 74.9K · Sold 17.8K
Granted 101.3K · Sold 50.9K
Granted 29.9K · Bought 3.0K
Granted 32.0K
Granted 99.5K · Bought 10.0K · Sold 90.4K
Granted 50.0K · Sold 75.0K
Granted 123.2K · Sold 97.75M
Granted 17.3K
Granted 29.7K
Granted 21.1K · Bought 3.4K
Granted 23.5K
Bought 10.0K
Granted 21.1K
Granted 312.9K · Bought 48.1K · Sold 46.5K
Granted 10.0K · Bought 10.0K
Granted 20.0K
Bought 11.0K
Granted 22.0K
Granted 4.1K
Granted 5.3K
Granted 53.7K · Sold 53.7K
Granted 31.5K · Sold 31.5K
Granted 2.5K
Bought 2.0K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Finnegan Paul J +6 co-filersDirector, 10% owner · 10 transactions | — | 274.96Mas of Sep 2021 | — | — | 97.70M |
| Madison Dearborn Partners LLC +1 co-filerDirector, 10% owner · 1 transaction | — | 37.46Mas of Nov 2021 | — | — | — |
| Finnegan Paul J +4 co-filersDirector, 10% owner · 1 transaction | — | 37.34Mas of Sep 2021 | — | — | — |
| OCH US Holding LLC +4 co-filers10% owner · 2 transactions | — | 37.02Mas of Mar 2023 | — | — | 26.48M |
| Kohlberg Offshore Investors V L P +5 co-filers10% owner · 2 transactions | — | 10.47Mas of Aug 2013 | — | — | 10.86M |
| Gray Adam +5 co-filersFormer Director & 10% Owner · 16 transactions | — | 5.40Mas of Aug 2019 | 1.72M | 4.20M | 2.85M |
| Coliseum Capital Partners L P +5 co-filersDirector, 10% owner · 2 transactions | — | 2.06Mas of Aug 2015 | — | 1.19M | — |
| Friedman Richard HFormer Director · 186 transactions | — | 781.8Kas of Apr 2012 | 1.54M | — | 1.77M |
| Rademacher John CharlesChief Executive Officer, Director · 31 transactions | — | 695.2K | 1.08M | 22.5K | — |
| Kraemer Harry M Jansen JrDirector · 20 transactions | — | 459.0K | 203.4K | 333.6K | — |
| Greenleaf Daniel EChief Executive Officer · 9 transactions | — | 438.0Kas of May 2019 | 496.7K | 31.0K | — |
| Shapiro Michael H.Chief Financial Officer · 26 transactions | — | 311.9Kas of Feb 2025 | 408.5K | 2.5K | 23.2K |
| Nasgovitz William JNo longer subject to Sec. 16 · 18 transactions | — | 311.8Kas of Feb 2010 | — | 117.5K | 532.6K |
| Rosenbaum StanleyFormer Officer · 22 transactions | — | 235.0Kas of Dec 2010 | 533.1K | 20.0K | 270.0K |
| Bronfein Michael GDirector · 6 transactions | — | 173.4Kas of May 2018 | 120.4K | 80.0K | 27.0K |
| Whitworth LukeChief Operating Officer · 24 transactions | — | 169.6K | 194.8K | — | — |
| Hubers David RDirector · 30 transactions | — | 168.3Kas of May 2014 | 97.1K | 101.0K | 11.2K |
| Deitsch StephenChief Financial Officer · 8 transactions | — | 151.2Kas of May 2019 | 178.1K | 10.0K | — |
| Goldstein MichaelDirector · 7 transactions | — | 148.9Kas of May 2018 | 133.9K | 25.0K | — |
| Smith Richard MPresident and CEO, Director · 3 transactions | — | 135.0Kas of Mar 2015 | 120.0K | 15.0K | — |
| Golding David WDirector · 18 transactions | — | 116.5Kas of Aug 2025 | 250.5K | 43.5K | — |
| Finnegan Paul J +5 co-filersFormer 10% Owner and Director · 1 transaction | — | 114.0Kas of Dec 2021 | — | — | — |
| Robbins Richard LDirector · 14 transactions | — | 113.5Kas of May 2014 | 63.5K | 50.0K | — |
| Denness RichardChief Commercial Officer · 19 transactions | — | 111.7Kas of Mar 2023 | 197.4K | — | — |
| Sethna MeenalChief Financial Officer · 3 transactions | — | 98.3K | 82.1K | 16.2K | — |
| Nguyen TriciaDirector · 5 transactions | — | 89.7Kas of May 2017 | 89.7K | — | — |
| Sullivan Timothy PDirector · 26 transactions | — | 82.4K | 139.6K | 44.2K | 97.75M |
| Stalmack KathrynGeneral Counsel · 4 transactions | — | 81.4Kas of Apr 2019 | 83.6K | — | — |
| Booker HarrietCHIEF OPERATING OFFICER · 24 transactions | — | 80.8Kas of Jun 2022 | 386.8K | — | 48.0K |
| Tran HaiChief Financial Officer · 2 transactions | — | 77.9Kas of May 2014 | 100.0K | — | — |
| Smyser CollinGC & Corporate Secretary · 23 transactions | — | 77.5K | 108.8K | 2.5K | — |
| Arlotta JohnDirector · 6 transactions | — | 71.0Kas of May 2024 | 117.5K | — | — |
| Samuels Stuart ADirector · 12 transactions | — | 66.5Kas of May 2014 | 85.9K | 3.0K | 22.4K |
| Collns Charlotte WDirector · 8 transactions | — | 63.8Kas of May 2014 | 63.5K | 300 | — |
| Sahney NitinDirector · 5 transactions | — | 61.7Kas of May 2023 | 107.8K | — | — |
| Ordemann ThomasExecutive Vice President · 1 transaction | — | 61.5Kas of Dec 2009 | — | — | 41.3K |
| Frieder Samuel PReporting owner · 5 transactions | — | 50.0Kas of May 2014 | 50.0K | — | — |
| Stiver Brian EdwardSVP National Infusion Sales · 1 transaction | — | 50.0Kas of Mar 2013 | 50.0K | — | — |
| Woodward GordonReporting owner · 5 transactions | — | 50.0Kas of May 2014 | 50.0K | — | — |
| Grashoff Christopher L.Chief Growth Officer · 16 transactions | — | 44.1K | 38.0K | — | — |
| Reagan Brian JEVP · 21 transactions | — | 42.5Kas of Jan 2009 | 135.1K | — | 28.0K |
| Schott AlexSenior Vice President · 1 transaction | — | 40.8Kas of Feb 2018 | — | — | — |
| Holubiak Myron ZDirector · 42 transactions | — | 40.0Kas of May 2016 | 146.1K | — | 96.1K |
| Schelhammer Steven KarlFormer director · 4 transactions | — | 40.0Kas of Mar 2010 | 20.5K | 30.0K | 10.5K |
| Difazio Louis DRDirector · 4 transactions | — | 36.0Kas of Apr 2011 | 33.5K | — | — |
| Corvese Russel JSVP of Columbus Infusion · 6 transactions | — | 35.4Kas of Mar 2012 | 74.9K | — | 17.8K |
| Bavaro MichaelChief Human Resources Officer · 36 transactions | — | 33.2K | 101.3K | — | 50.9K |
| Bierbower Elizabeth DDirector · 6 transactions | — | 32.9K | 29.9K | 3.0K | — |
| Deckmann NatashaDirector · 7 transactions | — | 32.0K | 32.0K | — | — |
| Posner Barry ASee General Remarks · 27 transactions | — | 30.4Kas of Oct 2011 | 99.5K | 10.0K | 90.4K |
| Friedman ScottSenior Vice President · 15 transactions | — | 30.3Kas of May 2010 | 50.0K | — | 75.0K |
| Betten Elizabeth QuadrosDirector · 20 transactions | — | 29.2Kas of May 2025 | 123.2K | — | 97.75M |
| Maggio NicoleChief Accounting Officer · 12 transactions | — | 28.5K | 17.3K | — | — |
| Adewunmi FemiChief Medical Officer · 6 transactions | — | 25.3K | 29.7K | — | — |
| Wright Norman L.Director · 5 transactions | — | 24.5K | 21.1K | 3.4K | — |
| Kepler JodyChief Compliance Officer · 2 transactions | — | 23.5Kas of Apr 2019 | 23.5K | — | — |
| Kreger Jeffrey MChief Financial Officer · 2 transactions | — | 22.6Kas of Nov 2016 | — | 10.0K | — |
| Bodem Barbara W.Director · 4 transactions | — | 21.1K | 21.1K | — | — |
| Pate R CarterDirector · 30 transactions | — | 20.6K | 312.9K | 48.1K | 46.5K |
| Jorden YonDirector · 3 transactions | — | 20.0Kas of Mar 2015 | 10.0K | 10.0K | — |
| Luthin James ChrisSVP & Chief Operating Officer · 2 transactions | — | 20.0Kas of Jul 2016 | 20.0K | — | — |
| Saracco MichaelSVP, Specialty Services · 2 transactions | — | 20.0Kas of Mar 2012 | — | 11.0K | — |
| Brandt EricDirector · 4 transactions | — | 19.4K | 22.0K | — | — |
| Graves Mary JaneChief Financial Officer · 1 transaction | — | 15.9Kas of Apr 2011 | 4.1K | — | — |
| Evans DaveSVP, Strategic Operations · 1 transaction | — | 6.7Kas of Mar 2012 | — | — | — |
| Berman Clifford ESEE REMARKS · 1 transaction | — | 5.3Kas of Feb 2021 | 5.3K | — | — |
| Bogusz PatriciaVice President, Finance · 7 transactions | — | 5.1Kas of Aug 2013 | 53.7K | — | 53.7K |
| colucci danielVice President, PBM Services · 9 transactions | — | 2.6Kas of Aug 2013 | 31.5K | — | 31.5K |
| Kampstra Robert RCHIEF ACCOUNTING OFFICER · 1 transaction | — | 2.5Kas of Feb 2021 | 2.5K | — | — |
| Nielsen Alan TroyDirector · 1 transaction | — | 2.0Kas of May 2020 | — | 2.0K | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over all recorded history: -330.19M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.